Question 1

How does the Dialogues Time to Talk program work alongside the medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program clinical trial (NCT00401726). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program clinical trial (NCT00401726). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program clinical trial (NCT00401726). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any other treatment options I should consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program clinical trial (NCT00401726). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects from the medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program clinical trial (NCT00401726). Contact the study team or your healthcare provider for specific answers.

What this study is about